Document Detail


Localization of malignant melanoma using monoclonal antibodies.
MedLine Citation:
PMID:  2009063     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Finding a screening test to evaluate patients with cancer for occult metastatic disease, as well as imaging all known disease, is a goal of research efforts. Twenty-nine evaluable patients with deeply invasive (stage I), regional nodal (stage II), or systemic (stage III) melanoma underwent imaging by administration of a preparation of the antimelanoma antibody labeled with technetium 99m. Scan results indicated that 28 of 32 confirmed metastatic sites were imaged with this technique (88% sensitivity). Analysis of the individual positive sites revealed that nodal basins and visceral metastases accounted for the highest percentage of metastatic sites imaged, with 14 (88%) of 16 nodal basin metastases and all four visceral metastases being detected through imaging. Occult nodal disease was detected in the iliac nodal chain in two of the 29 patients. The imaging of benign tumors and nodal basins not containing disease accounted for a confirmed false-positive rate of 21%. Three (10%) of the 29 scan results were confirmed to be false-negative. In vivo tumor localization with monoclonal antibodies showed a sensitivity similar to that of other roentgenographic procedures for identifying metastatic disease and was useful in two of three patients in identifying occult iliac nodal disease, a region that is difficult to evaluate with physical examination and other imaging modalities.
Authors:
J Wasselle; J Becker; W Cruse; C Espinosa; C Cox; D Reintgen
Related Documents :
15383203 - Image-guided cancer therapy using pet/ct.
14700483 - The role of positron emission tomography in evaluating mediastinal lymph node metastase...
17101183 - Structural and functional assessment of arrhythmogenic right ventricular dysplasia/card...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Archives of surgery (Chicago, Ill. : 1960)     Volume:  126     ISSN:  0004-0010     ISO Abbreviation:  Arch Surg     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-04-30     Completed Date:  1991-04-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9716528     Medline TA:  Arch Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  481-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, University of South Florida, Tampa 33682-0179.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antibodies, Monoclonal / diagnostic use*
False Negative Reactions
False Positive Reactions
Humans
Male
Melanoma / diagnosis*,  pathology,  radiography,  radionuclide imaging
Middle Aged
Neoplasm Metastasis
Sensitivity and Specificity
Technetium / diagnostic use
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 7440-26-8/Technetium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lymphokine-activated killer cell suppressor factor in malignant effusions.
Next Document:  The importance of anatomic site in prognosis in patients with cutaneous melanoma.